Results comparable to fresh frozen
Generates sequence alignments covering 98% of the genome at a depth of 20x or greater, when sequenced at a depth of 70x for whole genome sequencing.
Unlock new insights from tumor samples with 98% sequence alignments covered at a depth of 20x. This process produces reliable, high-quality results for whole genome, exome, or multi-omic analysis comparable to fresh frozen-derived data, enabling quality mutation and copy number variation analyses.
SeqPlus sequencing methodology enables robust whole-genome sequencing, true variant detection, and novel genomic insights from archival esophageal carcinoma FFPE samples.Learn more
WuXi NextCODE offers access to Illumina's TruSightTM Oncology 500 (TSO 500).Learn More
Presentation of AstraZeneca's findings that our SeqPlus gives improved coverage of genes from FFPE samples, enabling more efficient exome sequencing.Learn More
Isolating sufficient quality DNA from samples is a major challenge in genomic research. Setbacks can raise costs, cause delays, and lead to failed studies. A new process from WuXi NextCODE, SeqPlus, offers time and cost savings with excellent results. SeqPlus greatly improves DNA extraction from formalin-fixed, paraffin-embedded samples.Learn More